Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Terumo Cardiovascular Group and Hemostasis Introduce BoneSeal® Bone Hemostat


ANN ARBOR, Mich., Feb. 19, 2019 /PRNewswire/ -- Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, and Hemostasis, LLC., today announced a three-year exclusive distribution agreement that will bring BoneSeal® bone hemostat to the United States cardiac surgery market. BoneSeal hemostat is used as a mechanical barrier to control bleeding from cut or damaged bone surfaces. It is comprised of a blend of resorbable, synthetic polymers and biocompatible minerals that promotes bone growth.(1) 

BoneSeal hemostat is a new generation of bone hemostat that effectively stops bleeding upon application during sternotomy procedures and promotes bone growth during post-operative healing.(1)

Cardiac surgeons have long-attempted to use various hemostats to manage bleeding from sternotomies, including beeswax, putties, powders and gelatin. BoneSeal hemostat offers a new, all-in-one solution to manage bone hemostasis that is easy to apply and bioabsorbable.

"Terumo CV Group is excited to partner with Hemostasis to bring this innovative product to cardiac surgeons," said Robert DeRyke, Terumo Cardiovascular Group's President and CEO. "Our new agreement to distribute BoneSeal hemostat is yet another way we can positively impact patient care."

BoneSeal hemostat handles much like beeswax and works immediately to achieve bone hemostasis upon application. With BoneSeal hemostat, surgeons can take control of hemostasis and post-operative bleeding, giving patients a better start to healing.(1)

1.     Tham T, Roberts K, Shanahan J, Burban J, Constantino P. Analysis of bone healing with a novel bone wax substitute compared with bone wax in a porcine bone defect model. Future Science OA. 2018 Sep; 4(8): FSO326.

About Terumo Cardiovascular Group

Terumo Cardiovascular Group manufactures and markets medical devices for cardiac and vascular surgery with an emphasis on cardiopulmonary bypass, intra-operative monitoring and vascular grafting. The company is headquartered in Ann Arbor, Michigan, with manufacturing operations in the U.S., Europe and Asia. It is one of several subsidiaries of Terumo Corporation of Japan that is focused exclusively on cardiac and vascular specialties. For more information, visit www.terumo-cvgroup.com.

About Hemostasis
Hemostasis designs and manufactures advanced biomaterial-based technologies to facilitate hemostasis and wound healing. Hemostasis products are used in procedures to treat disorders and stop bleeding in sinus, cardiac, orthopedic, vascular, soft tissue and solid organs. Hemostasis is headquartered in Saint Paul, Minnesota. For more information, visit www.hemostasisllc.com.

 

SOURCE Terumo Cardiovascular Group


These press releases may also interest you

at 08:53
NT Solar, a national tax credit syndicator with a mission to provide affordable clean energy access through investments in renewables and battery projects with strong ESG attributes, is thrilled to announce a series of four strategic solar tax credit...

at 08:48
In a landmark collaboration, The emoji company GmbH, in partnership with UNIS Technology Ltd., has announced the development of emoji® branded entertainment centers, under the brand name emojiplanettm. This strategic initiative, brokered by WildBrain...

at 08:47
Sales Focus Inc. (SFI), a global leader in the sales outsourcing industry, has won a Bronze Stevie® Award in the Sales Outsourcing Provider of the Year category in the 2024 Stevie Awards for Sales & Customer...

at 08:47
Finopotamus, the only online resource providing in-depth technology coverage exclusively to credit unions, today announced the launch of the inaugural Payments Industry Leaders Forum (PILF), the second in a Finopotamus series of knowledge portals...

at 08:46
Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr. Roohi Jeelani, and Jerry Lanchbury, Ph.D as new members joining their Medical and...

at 08:46
JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") , one of the largest and most innovative solar module manufacturers in the world, today announced that the Company filed its annual report on Form 20-F for the fiscal year ended December...



News published on and distributed by: